Covered recipient · General Payments record
ALEX MCCOLLOSTER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$650.37
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $398.26 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $105.94 | 1 |
| Lilly USA, LLC | $79.99 | 4 |
| Amgen Inc. | $50.99 | 3 |
| DEXCOM, INC. | $39.51 | 2 |
| Acerta Pharma LLC | $29.12 | 1 |
| Exact Sciences Corporation | $29.04 | 2 |
| PFIZER INC. | $19.72 | 1 |
| GlaxoSmithKline, LLC. | $15.88 | 1 |
| Lundbeck LLC | $14.93 | 1 |
| Novo Nordisk AS | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.13 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117322890 | CMS |
| Amgen Inc. | $17.60 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111647434 | CMS |
| Amgen Inc. | $18.26 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117322892 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.12 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104466520 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $105.94 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086257572 | CMS |
| Dexcom, Inc. | $22.98 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153277352 | CMS |
| Dexcom, Inc. | $16.53 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153277354 | CMS |
| Exact Sciences Corporation | $13.70 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114779921 | CMS |
| Exact Sciences Corporation | $15.34 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114779926 | CMS |
| GlaxoSmithKline, LLC. | $15.88 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115968640 | CMS |
| Lilly USA, LLC | $17.91 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012777 | CMS |
| Lilly USA, LLC | $19.51 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135996250 | CMS |
| Lilly USA, LLC | $18.92 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136019520 | CMS |
| Lilly USA, LLC | $23.65 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012779 | CMS |
| Lundbeck LLC | $14.93 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145944522 | CMS |
| Novo Nordisk Inc | $13.14 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097336766 | CMS |
| PFIZER INC. | $19.72 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131915412 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.